New targeted therapy shows strong precision in treating chronic myeloid leukemia

This announcement highlights a breakthrough targeted therapy for chronic myeloid leukemia (CML) that demonstrates improved effectiveness and better tolerance. The new treatment has the potential to enhance the quality of life for patients living with CML.

Originally published by gnews